Balancing immunity and pathology in visceral leishmaniasis. - Wikidata - wikimedia - TriplyDB

Balancing immunity and pathology in visceral leishmaniasis.

Balancing immunity and pathology in visceral leishmaniasis.

http://www.wikidata.org/entity/Q34587432

about

Possibilities and challenges for developing a successful vaccine for leishmaniasis The Contribution of Immune Evasive Mechanisms to Parasite Persistence in Visceral Leishmaniasis Determinants for the development of visceral leishmaniasis disease Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection Iron overload favors the elimination of Leishmania infantum from mouse tissues through interaction with reactive oxygen and nitrogen species Parasite load induces progressive spleen architecture breakage and impairs cytokine mRNA expression in Leishmania infantum-naturally infected dogs Regulation of immunity during visceral Leishmania infection Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends Leishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasis Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis Deficiency of p110δ isoform of the phosphoinositide 3 kinase leads to enhanced resistance to Leishmania donovani Combined Immune Therapy for the Treatment of Visceral Leishmaniasis Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice.Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infection Co-ordinated gene expression in the liver and spleen during Schistosoma japonicum infection regulates cell migration.Antigen-Pulsed CpG-ODN-Activated Dendritic Cells Induce Host-Protective Immune Response by Regulating the T Regulatory Cell Functioning in Leishmania donovani-Infected Mice: Critical Role of CXCL10.Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease.Immune regulation during chronic visceral leishmaniasis.Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation.Leishmaniasis in the middle East: incidence and epidemiology.Involvement of CD4⁺ Foxp3⁺ regulatory T cells in persistence of Leishmania donovani in the liver of alymphoplastic aly/aly mice.UCP2 deficiency helps to restrict the pathogenesis of experimental cutaneous and visceral leishmaniosis in mice Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB/c mouse versus Syrian hamster model.Immunobiology of visceral leishmaniasis.Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.The malnutrition-related increase in early visceralization of Leishmania donovani is associated with a reduced number of lymph node phagocytes and altered conduit system flow.Differential Regulation of the Immune Response in the Spleen and Liver of Mice Infected with Leishmania donovani.Development of Vaccines against Visceral Leishmaniasis Effectiveness and safety of short course liposomal amphotericin B (AmBisome) as first line treatment for visceral leishmaniasis in Bangladesh.Role of co-stimulation in Leishmaniasis Compartmentalized Immune Response in Leishmaniasis: Changing Patterns throughout the Disease The Challenge of Stability in High-Throughput Gene Expression Analysis: Comprehensive Selection and Evaluation of Reference Genes for BALB/c Mice Spleen Samples in the Leishmania infantum Infection Model.Immunomodulation of host-protective immune response by regulating Foxp3 expression and Treg function in Leishmania-infected BALB/c mice: critical role of IRF1.IFN-γ-induced macrophage antileishmanial mechanisms in mice: A role for immunity-related GTPases, Irgm1 and Irgm3, in Leishmania donovani infection in the liver.Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol.Resistance to visceral leishmaniasis is severely compromised in mice deficient of bradykinin B2-receptors.Iron acquisition within host cells and the pathogenicity of Leishmania Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model.

P2860

Q26749758-5C818783-AB2C-4FEB-8088-33B6C605006B Q26752513-2956E3AC-4F1F-4A8E-8A39-6281408420A7 Q27027871-E51923B4-067E-46BA-9002-1ABEE98A1C09 Q27304818-B66FD65D-418D-4CF0-97EF-1481F55F32B2 Q27305261-9696240B-BEBA-4936-90AF-463143614BCA Q27310041-CF7CD501-88B2-4679-A6E2-0A95E8E5EFBE Q28066034-BCA14819-75F6-430E-8222-73B8EC1BDCE1 Q28474321-ADAD2093-F9CF-4B63-876C-B162A2877357 Q28483976-6B2E8883-16E6-4143-992E-5BA99BE13F87 Q28484622-044B043F-030B-47E4-B164-A755BF3FBD4E Q28486287-41CF5F92-A7EF-44CD-BA3E-749B5C77AC16 Q28539842-18974976-5182-44DA-A9FD-952D8B1213E6 Q28550162-AE6E766C-40BB-46C5-85A0-5D31AD676A15 Q28551736-EB5FFD38-D3C5-46E8-9D1E-30977DA4A7C7 Q30493887-35C55586-DF36-4AE0-8731-85616BE5E03D Q31036509-6060463D-E5DE-4D18-AC80-FFDC16CDC222 Q33587286-6406C795-A177-4CB0-9223-501B5083ABDD Q33709163-B1C28D98-2A55-4ED3-908C-7DB89483FC9D Q33749424-E180AF9E-BABF-450F-B600-7B96984E4EDB Q33881718-2AEE8020-AFB8-4918-8224-C6CC0B6778A5 Q34149280-4A8F297F-BFD2-4E9D-B658-0FE19815F415 Q34281996-EB687DFF-11AD-4EE3-B812-71F5348EFF64 Q34396137-7E916EF1-6ABB-47D6-9056-9DFE0946C7A4 Q34600718-73D3DDAA-C9C9-4849-8636-008EE9797DF1 Q34639315-4105AB06-BCE6-4C21-BA27-CD70E2ADE1A0 Q34641680-7CF2ECBE-2896-44D5-833B-8E73364AD63C Q34955529-99913F35-5693-41E0-9812-35EC38CD50AD Q34965743-21628382-1387-4F70-8CD1-30B824064DDF Q35127522-E5669209-400B-4A00-9805-AED589FEA608 Q35207606-E2294653-B985-48F0-9445-5068380F47FD Q35249954-ED9A82DF-1507-46BD-9A02-C33FCA9346CA Q35566850-36B5CE97-B38D-48D2-B02B-2FF802B529E2 Q36015750-3C990201-F207-4310-8BA3-CF3DBCCFCADE Q36144523-F7A59289-5A5D-4E91-875D-47CA4960F348 Q36226474-B448AC4A-C3FE-4930-B83E-FFFF1AB692D3 Q36267823-9BA1111D-E8DE-49B3-B5A3-215F3CD4ACA3 Q36387245-F4FCD415-C3DB-45F2-898D-210F7E3402DC Q36444714-04D1A002-0F03-4641-BC24-7A2F4AC95B8B Q36631531-D7A236EF-7193-474B-B5E7-DD6E2B8C7F88 Q36678092-0EE8EBEF-FB83-415A-A088-938FFA90B47A

P2860

Balancing immunity and pathology in visceral leishmaniasis.

http://www.wikidata.org/entity/Q34587432

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Balancing immunity and pathology in visceral leishmaniasis.

@ast

Balancing immunity and pathology in visceral leishmaniasis.

@en

Balancing immunity and pathology in visceral leishmaniasis.

@nl

type

label

Balancing immunity and pathology in visceral leishmaniasis.

@ast

Balancing immunity and pathology in visceral leishmaniasis.

@en

Balancing immunity and pathology in visceral leishmaniasis.

@nl

prefLabel

Balancing immunity and pathology in visceral leishmaniasis.

@ast

Balancing immunity and pathology in visceral leishmaniasis.

@en

Balancing immunity and pathology in visceral leishmaniasis.

@nl

P1433

Q34587432-5D4D01A6-88FC-48A7-959C-646EFC0151DA

P1476

Q34587432-B07D991E-1E49-4A22-9555-848A3023563A

P2093

Q34587432-BF64CE20-B312-42B4-95A6-BEDF9A95E894

P2860

Q34587432-004ACC2E-9432-4A8A-A853-66039ADE4D9A

Q34587432-00BB4D41-0947-4C2D-BABF-6B83F114ADF4

Q34587432-0C8F1FD3-C1CB-4A75-9A5E-77B0AA7880AB

Q34587432-0C94C79A-8FCD-4CED-90FC-9C1D588D0DAE

Q34587432-0FCD287D-F857-4986-AA2F-0A8CD76A77AF

Q34587432-1553EDCF-0F57-429D-B724-CC25DC119A41

Q34587432-1628BCFC-19E5-490F-9222-5306998B831C

Q34587432-16C2D95E-ED3F-44D9-932C-1448668E7D3C

Q34587432-18E8EA01-3179-4713-BF40-D75006FA28C4

Q34587432-1B2AE379-A3DD-4C1C-9963-F508AB3AA85F

P304

Q34587432-26C7643F-94D2-4A2D-B39A-C06586C734B1

P31

Q34587432-B3628885-7EF9-4D90-B459-E4A1EFC2D150

P356

Q34587432-B47FB315-CFEA-4972-8EE7-007C97C0C35F

P433

Q34587432-70A4C997-5EE7-4F3B-B99F-BB77AA821A63

P478

Q34587432-7769D665-965D-4C3D-9475-EEED1589BC7A

P50

Q34587432-122807A6-CECF-4046-8141-06A070F6B1DC

P577

Q34587432-E31041F2-CDB1-4665-9192-044C6F84F725

P5875

Q34587432-A5237455-0635-41F3-A4A3-3734568FB94C

P698

Q34587432-E8D16742-C145-4CED-A101-FF70FCDAE6C1

P921

Q34587432-6030E072-C005-4BDB-807F-18DE589981A0

Q34587432-ac8d9e44-4e5f-48cf-996e-9dffa2305ed7

P356

P1433

Immunology & Cell Biology

P1476

Balancing immunity and pathology in visceral leishmaniasis.

@en

P2093

Amanda C Stanley

http://www.w3.org/2001/XMLSchema#string

P2860

In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma

Interleukin 10 production correlates with pathology in human Leishmania donovani infections

Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome

Structure and function of the spleen

Cells in the marginal zone of the spleen

Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue

The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene

The TGF-beta response to Leishmania chagasi in the absence of IL-12

Chemokines: a new classification system and their role in immunity

Drug resistance in leishmaniasis

P304

138-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ICB7100011

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

Christian R. Engwerda

P577

2006-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6653550

http://www.w3.org/2001/XMLSchema#string

P698

17146466

http://www.w3.org/2001/XMLSchema#string

P921

visceral leishmaniasis